Science Explorer Interactive view Map
Hospital / health system · Shanxi · China

Shanxi Provincial Cancer Hospital

In research, Shanxi Provincial Cancer Hospital stands highest in Medicine (#3,860 of 10,443 worldwide), Health Sciences (#4,967 of 11,982 worldwide) and Life Sciences (#4,797 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Oncology and Pulmonary and Respiratory Medicine — Cancer Research is 16.4× its share of world research.

sxzlyy.comROR OpenAlex
World rank, 2022–2025
#9,074
of 28,054 · #17,825 all time
Rank in China
#1,719
of 3,058
Research works
1.3k
▼ 13% vs 2013–17
Citations
8.1k
6.1 per fractional work
Top-10% rate
15.5%
record average 16.5%
Open access
35%
world 28%

What is Shanxi Provincial Cancer Hospital known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #3,860 of 10,443 15.2%192 #8159
Health SciencesDomain #4,967 of 11,982 15.2%196 #10466
Life SciencesDomain #4,797 of 7,800 16.3%89 #8649
Biochemistry, Genetics and Molecular BiologyField #3,311 of 3,579 15.0%72 #6749

Each strip is that field’s whole ranked pool, with the notch where Shanxi Provincial Cancer Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#8,159 #3,860
  2. Health Sciences#10,466 #4,967
  3. Life Sciences#8,649 #4,797
  4. Biochemistry, Genetics and Molecular Biology#6,749 #3,311
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Shanxi Provincial Cancer Hospital specialise in?

Where its research is concentrated relative to its size: Cancer Research takes 16.4× the share of its output that it takes of world research.

  1. Cancer ResearchSubfield · 22.3 works16×
  2. OncologySubfield · 52.2 works15×
  3. Pulmonary and Respiratory MedicineSubfield · 35.1 works7.3×
  4. Molecular BiologySubfield · 41.1 works4.3×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.30× its world share, 72 worksBiochemistry, Geneti…Immunology and Microbiology: 2.95× its world share, 9 worksImmunology and Micro…Neuroscience: 0.94× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.84× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.47× its world share, 2 worksChemistryComputer Science: 0.19× its world share, 5 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.35× its world share, 1 worksEnergyEngineering: 0.18× its world share, 8 worksEngineeringEnvironmental Science: 0.05× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.70× its world share, 8 worksMaterials ScienceMathematics: 0.13× its world share, 0 worksMathematicsPhysics and Astronomy: 0.14× its world share, 1 worksPhysics and AstronomyDentistry: 0.36× its world share, 0 worksDentistryHealth Professions: 0.31× its world share, 3 worksHealth ProfessionsMedicine: 3.19× its world share, 192 worksMedicineNursing: 0.81× its world share, 1 worksNursingDecision Sciences: 0.12× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.09× its world share, 1 worksEconomics, Econometr…Psychology: 0.07× its world share, 1 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.3×. Every wedge is a field page.

Who are the top researchers at Shanxi Provincial Cancer Hospital?

Ranked on the composite score, Lili Du, 张宏宇 and 赵铭 lead among researchers whose main affiliation is Shanxi Provincial Cancer Hospital.

  1. 1 Lili Du China · #566,242 worldwide 35 citations · 21 works
  2. 2 张宏宇 China · #635,519 worldwide 0 citations · 31 works
  3. 3 赵铭 China · #664,382 worldwide 0 citations · 17 works
  4. 4 Ruifang Sun China · #929,347 worldwide 49 citations · 15 works
  5. 5 Xiaotang Yang China · #976,506 worldwide 7 citations · 16 works
  6. 6 Liping Su China · #1,135,044 worldwide 16 citations · 26 works
  7. 7 Haiyi Liu China · #1,214,703 worldwide 27 citations · 20 works
  8. 8 Yanfeng Xi China · #1,357,457 worldwide 25 citations · 32 works
  9. 9 Jinfen Wang China · #1,404,648 worldwide 22 citations · 15 works
  10. 10 Jianzhong Cao China · #1,506,541 worldwide 7 citations · 17 works
All ranked researchers at Shanxi Provincial Cancer Hospital

Which keywords describe research at Shanxi Provincial Cancer Hospital?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Tumor Microenvironment, Metastasis, Immunotherapy, Gene Expression, Clinical Practice Guidelines and Biomarkers.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer45▲ 11×43 topics
  2. Chemotherapy37▲ 17×21 topics
  3. Tumor Microenvironment27▲ 20×8 topics
  4. Inflammation22▲ 3.4×55 topics
  5. Metastasis21▲ 20×12 topics
  6. Immunotherapy21▲ 9.5×17 topics
  7. Gene Expression20▲ 11×11 topics
  8. Clinical Practice Guidelines19▲ 11×13 topics
  9. Biomarkers19▲ 8.7×11 topics
  10. Targeted Therapy17▲ 25×4 topics
  11. Clinical Trials16▲ 7.8×11 topics
  12. Neoadjuvant Therapy16▲ 22×5 topics
  13. Prognostic Factors15▲ 11×13 topics
  14. Regulation15▲ 8.9×7 topics
  15. Biogenesis15▲ 27×3 topics
  16. Survival Analysis15▲ 17×6 topics
  17. Oxidative Stress14▲ 2.8×31 topics
  18. Radiotherapy13▲ 11×11 topics
  19. Endoscopic Resection12▲ 39×2 topics
  20. Immune Checkpoint Blockade11▲ 32×1 topic
  21. PD-1 and PD-L111▲ 32×1 topic
  22. PET Imaging11▲ 20×4 topics
  23. Lymphoma10▲ 21×4 topics
  24. Precision Medicine10▲ 6.8×8 topics
  25. Molecular Characterization10▲ 18×5 topics
  26. Preoperative Chemoradiotherapy10▲ 40×2 topics
  27. Cell Death10▲ 13×6 topics
  28. Adjuvant Therapy9▲ 24×2 topics
  29. Immunity9▲ 7.3×9 topics
  30. Tumor Markers9▲ 36×2 topics
  31. Epigenetic Regulation9▲ 13×3 topics
  32. Molecular Profiling9▲ 29×3 topics
  33. Rituximab8▲ 18×2 topics
  34. Treatment Guidelines8▲ 12×5 topics
  35. Chemoradiation8▲ 41×2 topics
  36. Breast Cancer8▲ 11×10 topics
  37. Genomic Profiling8▲ 25×2 topics
  38. Therapeutics8▲ 24×2 topics
  39. Gene Expression Profiling8▲ 30×2 topics
  40. ALK Inhibitors8▲ 39×1 topic

Which research topics does Shanxi Provincial Cancer Hospital publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Ferroptosis and cancer prognosis and Lymphoma Diagnosis and Treatment.

Cancer Immunotherapy and…11Cancer Immunotherapy and Biomarkers: 11 fractional worksLung Cancer Treatments a…8Lung Cancer Treatments and Mutations: 8 fractional worksFerroptosis and cancer prognosis: 7 fractional worksLymphoma Diagnosis and Treatment: 7 fractional worksMicroRNA in disease regulation: 7 fractional worksEsophageal Cancer Research and Treatment: 6 fractional worksGastric Cancer Management and Outcomes: 6 fractional worksRadiomics and Machine Le…6Radiomics and Machine Learning in Medical Imaging: 6 fractional worksCancer-related molecular mechanisms research: 6 fractional worksLung Cancer Research Studies: 6 fractional works
OncologyPulmonary and Respiratory MedicinePathology and Forensic MedicineCancer Research2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 11 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 8 works
  3. 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 7 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 7 works
  5. 5 MicroRNA in disease regulation Cancer Research 7 works
  6. 6 Esophageal Cancer Research and Treatment Surgery 6 works
  7. 7 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 6 works
  8. 8 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 6 works
  9. 9 Cancer-related molecular mechanisms research Cancer Research 6 works
  10. 10 Lung Cancer Research Studies Oncology 6 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.1%not open64.9%

World: 28% of research is openly available.

with international co-authors6.5%domestic only93.5%

World: 19% is written across borders.

How has Shanxi Provincial Cancer Hospital's research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shanxi

All research institutions in Shanxi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.